Showing results (141-150 of 157) with videos related to

Sort By:
Pageof 16
American Journal of Cancer Research|September 11, 2023
The efficacy and safety of bevacizumab as a salvage therapy for patients with advanced hepatocellular carcinoma targeting immune toleranceLonghao Zhang, Jingnan Xue, Nan Zhang, et al.
Nature Microbiology|March 24, 2023
SARS-CoV-2 restructures host chromatin architectureRuoyu Wang, Joo-Hyung Lee, Jieun Kim, et al.
International Journal of Cancer|March 6, 2023
Biomarkers of gut barrier dysfunction and risk of hepatocellular carcinoma in the REVEAL-HBV and REVEAL-HCV cohort studiesJessica L Petrick, Andrea A Florio, Jane Zen, et al.
Journal for Immunotherapy of Cancer|December 7, 2021
Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancersJinzhu Mao, Dongxu Wang, Junyu Long, et al.
Frontiers in Immunology|December 26, 2022
Efficacy of immune checkpoint inhibitors plus molecular targeted agents after the progression of lenvatinib for advanced hepatocellular carcinomaFucun Xie, Bowen Chen, Xu Yang, et al.
Targeted Oncology|March 22, 2019
Distribution of ALK Fusion Variants and Correlation with Clinical Outcomes in Chinese Patients with Non-Small Cell Lung Cancer Treated with CrizotinibYudong Su, Xiang Long, Yang Song, et al.
Journal for Immunotherapy of Cancer|June 9, 2023
CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicityJennifer Jess, Bonnie Yates, Alina Dulau-Florea, et al.
JCI Insight|June 17, 2025
Identification of HIF1A as a therapeutic target during SARS-CoV-2-associated lung injuryBentley Bobrow, Samuel D Luber, Paul Potnuru, et al.
Nature Communications|September 13, 2024
HIF-2α-dependent induction of miR-29a restrains T<sub>H</sub>1 activity during T cell dependent colitisAgnieszka K Czopik, Eóin N McNamee, Victoria Vaughn, et al.
Hepatology International|February 8, 2023
Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patientsXu Yang, Bowen Chen, Yanyu Wang, et al.
Pageof 16